Quetiapine Fumarate Tablet
Product Images NDC 70518-1918

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 70518-1918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (E5317b83 F487 441b 9095 A25a9560bc54 01)

Molecular Structure (E5317b83 F487 441b 9095 A25a9560bc54 01)
Chemical structure diagram of quetiapine fumarate showing the molecular components of the active ingredient. The structure includes a dibenzothiazepine moiety linked to a piperazine ring and fumarate ion representation.*
FDA Label Image

Figure 1 (E5317b83 F487 441b 9095 A25a9560bc54 02)

Figure 1 (E5317b83 F487 441b 9095 A25a9560bc54 02)
A line chart displaying the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. Two groups are compared: QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line), with the proportion of relapse rising more steeply in the PLA+LI/VAL group than in the QTP+LI/VAL group.*
FDA Label Image

Figure 2 (E5317b83 F487 441b 9095 A25a9560bc54 03)

Figure 2 (E5317b83 F487 441b 9095 A25a9560bc54 03)
A line graph showing the proportion of patients with relapse (%) over time (weeks) comparing two treatments: QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line). The vertical axis ranges from 0 to 100% and the horizontal axis spans 0 to 100 weeks. The PLA+LI/VAL group shows a higher proportion of relapse over time than the QTP+LI/VAL group.*
FDA Label Image

Image (35b3883e Bd69 43d5 8f5a 254dd92cd528 1584 1)

Image (35b3883e Bd69 43d5 8f5a 254dd92cd528 1584 1)
Quetiapine fumarate 200 mg oral tablets blister pack by RemedyRepack Inc. The pack contains 10 tablets arranged in two columns of five, with black circular tablets visible through silver foil backing.*
FDA Label Image

Image (9fb56acd 2611 4c7d B63f 1de0c57383ea 1628 1)

Image (9fb56acd 2611 4c7d B63f 1de0c57383ea 1628 1)
Quetiapine fumarate 200 mg oral tablets packaging by RemedyRepack Inc. The image shows a white blister card containing ten round tablets arranged in two columns of five. The tablets are packaged for prescription use and feature a standard commercial blister pack design.*
FDA Label Image

Mm1 (Quetiapine 200mg 70518 1918 00)

Mm1 (Quetiapine 200mg 70518 1918 00)
Quetiapine fumarate 200 mg tablet packaging label showing a quantity of 30 tablets. The label includes the NDC number 70518-1918-00 and states that the tablets are round, white, and scored with imprint Y18. It is repackaged by RemedyRepack Inc., located in Indiana, PA. The original manufacturer is Lupin Pharma, Baltimore, MD, with MFG NDC 68180-0448-01. Storage instructions and a QR code are also present.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Quetiapine fumarate 200 mg oral tablet, quantity 30, labeled RX only. The label shows the NDC number 70518-1918-00 and states repackaging by RemedyRepack Inc. It includes storage instructions and a warning to keep medication out of reach of children. The original manufacturer is Lupin Pharma, Baltimore, MD.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.